Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephane R B Heymans

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
European Heart Journal. Cardiovascular Imaging|October 31, 2021
The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fractionJerremy Weerts, Arantxa Barandiarán Aizpurua, Michiel T H M Henkens, et al.
European Heart Journal|September 3, 2025
Clinical care of family members of patients with dilated cardiomyopathyJob A J Verdonschot, Juan Pablo Kaski, Folkert W Asselbergs, et al.
European Heart Journal|January 30, 2018
Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmiasJob A J Verdonschot, Mark R Hazebroek, Kasper W J Derks, et al.
Cardiovascular Diabetology|July 31, 2025
Microvascular dysfunction across organs in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control studyJerremy Weerts, Blanche L M Schroen, Arantxa Barandiarán Aizpurua, et al.
European Journal of Heart Failure|April 29, 2025
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathyMartina Setti, Manuela Iseppi, Job A J Verdonschot, et al.
European Journal of Heart Failure|May 15, 2026
Improved Outcome up to Ten Years after Intravenous Immunoglobulin Therapy in Patients with Dilated CardiomyopathyMaurits A Sikking, Fabian Peisker, Henrike Maatz, et al.
Journal of the American Heart Association|July 21, 2022
Interatrial Block Predicts Life-Threatening Arrhythmias in Dilated CardiomyopathyMichiel T H M Henkens, Helena López Martínez, Jerremy Weerts, et al.
European Heart Journal. Imaging Methods and Practice|May 25, 2026
Study design and rationale of the Visualizing Subclinical Myocardial Changes with Shear Wave Elastography in Dilated Cardiomyopathy (VISUALIZE-DCM) trialMax F G H M Venner, Luuk van Knippenberg, Astrid B M Heymans, et al.
Circulation. Genomic and Precision Medicine|March 27, 2023
Prevalence and Clinical Consequences of Multiple Pathogenic Variants in Dilated CardiomyopathySophie L V M Stroeks, Ida G Lunde, Debby M E I Hellebrekers, et al.
Circulation. Arrhythmia and Electrophysiology|September 30, 2020
Cardiac Inflammation Impedes Response to Cardiac Resynchronization Therapy in Patients With Idiopathic Dilated CardiomyopathyJob A J Verdonschot, Jort J Merken, Antonius M W van Stipdonk, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
European Heart Journal. Cardiovascular Imaging|October 31, 2021
The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fractionJerremy Weerts, Arantxa Barandiarán Aizpurua, Michiel T H M Henkens, et al.
European Heart Journal|September 3, 2025
Clinical care of family members of patients with dilated cardiomyopathyJob A J Verdonschot, Juan Pablo Kaski, Folkert W Asselbergs, et al.
European Heart Journal|January 30, 2018
Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmiasJob A J Verdonschot, Mark R Hazebroek, Kasper W J Derks, et al.
Cardiovascular Diabetology|July 31, 2025
Microvascular dysfunction across organs in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control studyJerremy Weerts, Blanche L M Schroen, Arantxa Barandiarán Aizpurua, et al.
European Journal of Heart Failure|April 29, 2025
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathyMartina Setti, Manuela Iseppi, Job A J Verdonschot, et al.
European Journal of Heart Failure|May 15, 2026
Improved Outcome up to Ten Years after Intravenous Immunoglobulin Therapy in Patients with Dilated CardiomyopathyMaurits A Sikking, Fabian Peisker, Henrike Maatz, et al.
Journal of the American Heart Association|July 21, 2022
Interatrial Block Predicts Life-Threatening Arrhythmias in Dilated CardiomyopathyMichiel T H M Henkens, Helena López Martínez, Jerremy Weerts, et al.
European Heart Journal. Imaging Methods and Practice|May 25, 2026
Study design and rationale of the Visualizing Subclinical Myocardial Changes with Shear Wave Elastography in Dilated Cardiomyopathy (VISUALIZE-DCM) trialMax F G H M Venner, Luuk van Knippenberg, Astrid B M Heymans, et al.
Circulation. Genomic and Precision Medicine|March 27, 2023
Prevalence and Clinical Consequences of Multiple Pathogenic Variants in Dilated CardiomyopathySophie L V M Stroeks, Ida G Lunde, Debby M E I Hellebrekers, et al.
Circulation. Arrhythmia and Electrophysiology|September 30, 2020
Cardiac Inflammation Impedes Response to Cardiac Resynchronization Therapy in Patients With Idiopathic Dilated CardiomyopathyJob A J Verdonschot, Jort J Merken, Antonius M W van Stipdonk, et al.
Pageof 6